Irene Lopez-Fabuel

Irene Lopez-Fabuel

Auto-generated profile, based on publicly available information

Irene Lopez-Fabuel

Institute of Functional Biology and Genomics (IBFG), Universidad de Salamanca, CSIC, Salamanca, Spain

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ILIrene Lopez-Fabuel
Irene Lopez-Fabuel
JDJuliette Le Douce
Juliette Le Douce
ALAngela Logan
Angela Logan
AJAndrew M. James
Andrew M. James
GBGilles Bonvento
Gilles Bonvento
JBJuan Bolanos
Juan Bolanos
Significance: Neurons depend on oxidative phosphorylation for survival, whereas astrocytes do not. Mitochondrial respiratory chain (MRC) complexes can be organized in higher structures called supercomplexes, which dictate MRC electron flux and energy efficiency. Whether the specific metabolic shapes of neurons and astrocytes are determined by the specific organization of MRC complexes is unknown. Here, we found that, in astrocytes, most complex I is free, resulting in poor mitochondrial respiration but high reactive oxygen species (ROS) production. In contrast, neurons show complex I to be mostly embedded into supercomplexes, thus resulting in high mitochondrial respiration and low ROS production. Thus, MRC organization dictates different bioenergetics preferences of neurons and astrocytes impacting on ROS production, possibly playing a role in neurodegenerative diseases.

8 July 2020 in Nature
Verified
Journal Article
Closed access
PDF file
DJDaniel Jimenez-Blasco
Daniel Jimenez-Blasco
ABArnau Busquets-Garcia
Arnau Busquets-Garcia
EHEtienne Hebert-Chatelain
Etienne Hebert-Chatelain
RSRoman Serrat
Roman Serrat
CVCarlos Vicente-Gutierrez
Carlos Vicente-Gutierrez
GMGiovanni Marsicano
Giovanni Marsicano

17 July 2023 in Nature Metabolism
Verified
Journal Article
Open access
PDF file
BMBrenda Morant-Ferrando
Brenda Morant-Ferrando
DJDaniel Jimenez-Blasco
Daniel Jimenez-Blasco
PAPaula Alonso-Batan
Paula Alonso-Batan
JAJesus Agulla
Jesus Agulla
RLRebeca Lapresa
Rebeca Lapresa
JBJuan Bolanos
Juan Bolanos
Having direct access to brain vasculature, astrocytes can take up available blood nutrients and metabolize them to fulfil their own energy needs and deliver metabolic intermediates to local synapses1,2. These glial cells should be, therefore, metabolically adaptable to swap different substrates. However, in vitro and in vivo studies consistently show that astrocytes are primarily glycolytic3–7, suggesting glucose is their main metabolic precursor. Notably, transcriptomic data8,9 and in vitro10 studies reveal that mouse astrocytes are capable of mitochondrially oxidizing fatty acids and that they can detoxify excess neuronal-derived fatty acids in disease models11,12. Still, the factual metabolic advantage of fatty acid use by astrocytes and its physiological impact on higher-order cerebral functions remain unknown. Here, we show that knockout of carnitine-palmitoyl transferase-1A (CPT1A)—a key enzyme of mitochondrial fatty acid oxidation—in adult mouse astrocytes causes cognitive impairment. Mechanistically, decreased fatty acid oxidation rewired astrocytic pyruvate metabolism to facilitate electron flux through a super-assembled mitochondrial respiratory chain, resulting in attenuation of reactive oxygen species formation. Thus, astrocytes naturally metabolize fatty acids to preserve the mitochondrial respiratory chain in an energetically inefficient disassembled conformation that secures signalling reactive oxygen species and sustains cognitive performance.

24 July 2014 in Nature Communications
Verified
Journal Article
Closed access
PDF file
RRRaquel Requejo-Aguilar
Raquel Requejo-Aguilar
ILIrene Lopez-Fabuel
Irene Lopez-Fabuel
EFEmilio Fernandez
Emilio Fernandez
LMLuis M. Martins
Luis M. Martins
AAAngeles Almeida
Angeles Almeida
JBJuan Bolanos
Juan Bolanos

1 November 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
MBMaria J. Bueno
Maria J. Bueno
VJVeronica Jimenez-Renard
Veronica Jimenez-Renard
SSSara Samino
Sara Samino
JCJordi Capellades
Jordi Capellades
AJAlejandra Junza
Alejandra Junza
MQMiguel Quintela-Fandino
Miguel Quintela-Fandino
Upregulation of fatty acid synthase (FASN) is a common event in cancer, although its mechanistic and potential therapeutic roles are not completely understood. In this study, we establish a key role of FASN during transformation. FASN is required for eliciting the anaplerotic shift of the Krebs cycle observed in cancer cells. However, its main role is to consume acetyl-CoA, which unlocks isocitrate dehydrogenase (IDH)-dependent reductive carboxylation, producing the reductive power necessary to quench reactive oxygen species (ROS) originated during the switch from two-dimensional (2D) to three-dimensional (3D) growth (a necessary hallmark of cancer). Upregulation of FASN elicits the 2D-to-3D switch; however, FASN's synthetic product palmitate is dispensable for this process since cells satisfy their fatty acid requirements from the media. In vivo, genetic deletion or pharmacologic inhibition of FASN before oncogenic activation prevents tumor development and invasive growth. These results render FASN as a potential target for cancer prevention studies.

1 March 2013 in Journal of Virological Methods
Verified
Journal Article
Closed access
ILIrene López-Fabuel
Irene López-Fabuel
TWThierry Wetzel
Thierry Wetzel
EBEdson Bertolini
Edson Bertolini
ABAlexandra Bassler
Alexandra Bassler
EVEduardo Vidal
Eduardo Vidal
Antonio OlmosAntonio Olmos
Antonio Olmos